Search

Focuses on the psychiatric aspects of civilian disasters. Consideration of signs of emotional disturbance as an immediate reaction to a disaster; Decrease of the chances of maladaptive response due to psychiatric intervention; Guidelines for psychiatric management in disaster.

Presents correspondence on medicine in Great Britain and Europe. Reports on geriatric medicine; Danger from poisoning with antidepressant drug overdose; Procedures used in cataract extraction; Method in diagnosing familial hypercholesterolemia in childhood.

Investigates the use of serotonin reuptake inhibitors for the treatment of depression in Great Britain. Adverse effects of serotonin reuptake inhibitors; Association of serotonin reuptake inhibitors with mania; Advantages of the drugs over other antidepressants.

Editorial. States that the rates of morbidity, recurrence and death among patients treated for depression have highlighted the importance of long term psychological and pharmacological treatment. Distinction between continuation and maintenance treatment; Benefits of long term drug treatment; Causes of patients' death; Cost of a National Health Service (NHS) prescription for selective serotonin reuptake inhibitor in 1995.

Presents a case on the incidence of convulsive seizures following viloxazine treatment in patient with depressive psychosis in Great Britain. Details on the reaction of the patients to viloxazine; Evidence on the association between convulsive seizures and viloxazine; Speculations on the epileptogenic properties of viloxazine.

Editorial. Looks at the high risk of accidents for patients with depressive disorders. Numerous factors in this increased risk; Possibility of drug induced effects from cyclic antidepressants; Insufficient epidemiological data in this issue.

Editorial. Focuses on the use of antidepressants in treating depression and its complications and its link to suicide. Depression as an uncommon paradoxical adverse reaction to antidepressants; Higher fatality index of older drugs; Clinical and epidemiological perspective on the risks related to the use of tricyclic antidepressants and safer drugs.

Assesses the potential rapid antidepressant action of viloxazine. Pharmacological properties of viloxazine; Comparison between the efficacy of viloxazone and placebo; Side effects of viloxazone.